BackNovo Nordisk A/S Class B Overview

Novo Nordisk A/S Class B Profit Margin

Novo Nordisk A/S Class B (NONOF) has a profit margin of 33.92%, above the Healthcare sector average of 17.63%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

21.14%
↓ 20.78% YoY

As of Sep 2026

Annual Profit Margin (TTM)

33.92%
↑ 3.16% YoY

Trailing 12 months ending Sep 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Novo Nordisk A/S Class B (NONOF) FAQ

The latest profit margin for NONOF is 33.92% as of September 2026. That compares with 32.88% in the prior-year period — up 3.2% year over year. That is above the Healthcare sector average of 17.63%. Investors often review this figure alongside Novo Nordisk A/S Class B's historical trend and sector peers before judging valuation or financial health.

Over the past year, NONOF's profit margin moved from 32.88% to 33.92% — a 3.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Novo Nordisk A/S Class B's valuation or profitability profile.

Against Healthcare companies, NONOF currently prints 33.92% for profit margin, while the sector average sits near 17.63%. That is roughly 92.4% above the sector mean. Large gaps often invite a closer look at Novo Nordisk A/S Class B's growth, margins, and balance sheet.

Profit Margin shows how effectively Novo Nordisk A/S Class B converts resources into returns. At 33.92%, NONOF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 32.88% in the prior-year period — up 3.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting NONOF's profit margin (33.92%), review year-over-year change from 32.88%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.